Guest guest Posted March 29, 2004 Report Share Posted March 29, 2004 Deb, The most current research out of France regarding Ascorbic Acid (Vitamin C) showed remyelination results in mice with CMT Type 1A only. Human studies for 1A are pending. I have just received more information on this and as soon as I can will post. It seems that because 1A equals about 70 - to 80% of all CMT, that is why we are seeing TREATMENT RESEARCH like NT-3 and the Ascorbic Acid now - treatment in the 1A category would be for the greater number of those affected. But, do not despair...research is FINALLY into " treatment " so perhaps other types will fall into treatment/research studies soon. ~ Gretchen Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.